oramed_pharmaceuticals_inc
 
Press

Oramed in the News
press

Recent Articles about Oramed

Israel’s Prestigious President’s Conference to Feature Oramed Pharmaceuticals’ Revolutionary Oral Insulin Capsule
(Tues, May 6)
Oramed Pharmaceuticals Partners with OnQ Consulting for Phase 2B Trials on Its Oral Insulin Capsules
Business Wire (Thurs, Apr 17)
Oramed Pharmaceuticals Commences Phase 2A Clinical Trials in Israel
Business Wire (Tues, Apr 14)
Oramed Pharmaceuticals Granted Approval to Conduct Phase 2A Trials of Its Oral Insulin Capsule
Business Wire (Tues, Mar 18)
Oramed Pharmaceuticals Successfully Completes Phase 1B Clinical Trials of Oral Insulin Capsule
Business Wire (Tues, Mar 11)
Oramed Pharmaceuticals Teams up with OnQ Consulting
Business Wire (Wed, Jan 30)
Oramed Pharmaceuticals Commences Phase 1B Clinical Trials
Business Wire (Tues, Jan 22)
Insulin News That's Easy To Swallow
Business Wire (Tues, Jan 17)
Oramed Pharmaceuticals Successfully Completes Animal Studies for Phase 1B Clinical Trials Of Its Oral Insulin Capsule
Business Wire (Thu, Nov 15)
Oramed's CEO to Present at Rodman & Renshaw's Ninth Annual Healthcare Conference On November 6, 2007
Business Wire (Fri, Nov 2)
Oramed Pharmaceuticals Successfully Completes Phase 1A Trials
PR Newswire (Tue, Aug 14)
Oramed Pharmaceuticals Completes $2 million in Financing
Business Wire (Mon, Aug 6)
Oramed Pharmaceuticals Begins Phase 1 Human Clinical Trials
PrimeNewswire - 05/08/07
Shazamstocks.com Announces Profile Launch of Oramed Pharmaceuticals, Inc.
PrimeNewswire - 05/03/07
Oramed Pharmaceuticals Expands Product Line With the Addition of Two New Provisional Patents in the Intellectual Property Portfolio
PrimeNewswire - 05/01/07

Exclusive Interview With Oramed Pharmaceuticals Inc. CEO, Nadav Kidron on www.Wallst.Net
PR Newswire - 04/18/07

AllPennyStocks.com Releases a Special Report On Oramed Pharmaceuticals Inc.
PrimeNewswire - 04/11/07
Oramed Pharmaceuticals Begins Additions to an Advisory Board
PR Newswire - 04/10/07
Oramed Pharmaceuticals Rated 'Speculative Buy,' Target Price $1.20 by Beacon Equity Research
BusinessWire - 03/21/07
"Oramed Pharmaceuticals Announces Maiden Year Progress Report "
PR Newswire - 03/13/07
"Oramed Pharmaceuticals Announces the Completion of its World Renowned Scientific Board"
PR Newswire - 02/22/07
"Oramed Pharmaceuticals Inc. Adds Another Accomplished Member to Its Scientific Board"
PR Newswire - 02/21/07
"Oramed Pharmaceuticals Announces the Expansion of Its Scientific Board With a Prominent American Figure in Diabetes Research"
PR Newswire - 01/31/06
"Oramed Further Enhances World Renowned Scientific Board of Directors"
PR Newswire - 01/16/07
"Oramed Pharmaceutical, Inc. Adds to its Scientific Advisory Board"
PR Newswire - 01/09/2007
"Oramed Pharmaceuticals Discusses Benefits of Oral Insulin Capsule Versus Insulin Inhaler"
PR Newswire - 12/14/06
"Companies Present at Yale Club in New York City -- EQUITIES Announces Discovery Day Conference XIII"
Market Wire 11/27/06
"Oramed Pharmaceuticals Signs Manufacturing Agreement for Oral Insulin Pill"
PR Newswire - 11/02/06
"Oramed Pharmaceuticals Technology Patented with WIPO"
PR Newswire - 09/13/06
"Oramed Pharmaceuticals Obtains Dual Listing on Frankfurt Stock Exchange"
PRNewswire - 08/02/06
"Oramed Pharmaceuticals Receives MOH and IRB Approval to Begin Phase 1 Human Trials for Oral Insulin"
MARKET WIRE - 07/11/06
"Oral Insulin Pill Could Bring Relief to Millions"
Syndicated News - 06/20/06
"Exciting Growth Companies to Present at EQUITIES Summer Conference 2006 on June 16, at the Yale Club in NYC"
MARKET WIRE - 06/13/06
"Oramed Pharmaceuticals combats diabetes with oral insuli"
Oramed Pharmaceuticals - 06/12/06
"Integrated Security Technologies Complete Acquisition of Oral Insulin Patent Application "
Integrated Security Technologies, Inc. - 03/13/06
"Insulin pill offers hope for diabetes"
The Jerusalem Post - 07/05/05

 

 

 Breakthrough medical technology is leading to a
better-controlled, brighter life for diabetics—the way nature intended!

 

© 2008. Oramed Pharmaceuticals, All Rights Reserved.